Skip redundant pieces

Clinical Trials

The following clinical trials are currently recruiting participants. If you would like more information about the trial or how to participate, please contact the study coordinator.

Trial Name

Title

Sponsor

Condition

Status

Study Coordinator

Vit D 

Impact of vitamin D therapies on monocyte function in chronic kidney disease

Internal Medicine-K12 

CKD stage 3/4

Recruiting

Cathy Creed

 NOCTURNE
290

 Double-blinded trial to compare the efficacy, tolerability, and safety of Tolvaptan. Modified and Immediate release formulations in subjects with ADPKD

 Otsuka

 ADPKD

 Recruiting

Sheri Copeland

OVERTURE
291 

 A multi-center, longitudinal, observational study of subjects with ADPKD

 Otsuka

 ADPKD

 Recruiting

 Cathy Creed

MODIFIER
ADPKD study

Identifying genetic modifiers in ADPKD

NIH

ADPKD

Recruiting

Cathy Creed

FONT II

Novel therapies for resistant focal segmental glomerulosclerosis (FSGS): A phase 2 clinical trial

NIH

FSGS

Recruiting

Beth Courtney

MENTOR 

Membranous nephropathy trial of Rituximab multi-center randomized controlled trial of Rituximad Vs Cycolsporine in the TX of idiopathis membranous nephropathy (IMN)

 NIH

 ADKPKD

 Recruiting

 Cathy Creed

Abbreviations: CKD, chronic kidney disease; ESRD, end-stage renal disease; ADPKD, autosomal dominant polycystic kidney disease; FSGS, focal segmental glomerulosclerosis

 

 

The following clinical trials are active and NOT currently recruiting participants. If you would like more information about the trial, please contact the study coordinator.

 

Trial Name

Title

Sponsor

Condition

Status

Study Coordinator

TEMPO 3(271)

Multi-center, open-label, extension study to evaluate the long-term efficacy and safety of oral tolvaptan tablet regimens in subjects with autosomal dominant polycystic kidney disease

Otsuka

ADPKD

Active/Not Recruiting

Sheri Copeland

CRISP 3

Consortium for radiologic imaging studies of polycystic kidney disease

NIH

ADPKD

Active/Not Recruiting

Marilyn Logan
Beth Courtney

HALT-PKD

Halt progression of polycystic kidney disease: efficacy of renin-angiotensin-aldosterone axis blockade in preventing/slowing renal function decline in ADPKD

NIH

ADPKD

Active/Not Recruiting

Pam Lanza
Beth Courtney

 


Contact information

 

Sheri Copeland RN, Lead Study Coordinator      (913) 588-7691       scopeland2@kumc.edu

Cathy Creed RN, Study Coordinator                  (913) 588-0053       ccreed@kumc.edu

Elizabeth Courtney RN, Study Coordinator         (913) 588-7609       bcourtney@kumc.edu

Pam Lanza RN, Study Coordinator                    (913) 588-8983       planza@kumc.edu

Marilyn Logan,RN Study Coordinator                 (913) 588-3985       mlogan@kumc.edu


     Last modified: Dec 19, 2012